Skip to main content
Livermore
Livermore
ZHEN

Passage BIO, Inc.

PASG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001787297

No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Passage BIO, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
51
−1 vs. Q4 2023
Shares held
40.3M
+7.54M (+23.0%) vs. Q4 2023
Total value
$54.4M
+$21.3M (+64.4%) vs. Q4 2023
New holders
7
13 more added
Sold out
8
14 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 51 institutions
Q1 2021: 90 institutionsQ2 2021: 102 institutionsQ3 2021: 103 institutionsQ4 2021: 102 institutionsQ1 2022: 110 institutionsQ2 2022: 87 institutionsQ3 2022: 76 institutionsQ4 2022: 68 institutionsQ1 2023: 59 institutionsQ2 2023: 56 institutionsQ3 2023: 51 institutionsQ4 2023: 52 institutionsQ1 2024: 51 institutionsQ2 2024: 45 institutionsQ3 2024: 45 institutionsQ4 2024: 46 institutionsQ1 2025: 42 institutionsQ2 2025: 41 institutionsQ3 2025: 32 institutionsQ4 2025: 30 institutionsQ1 2026: 35 institutionsQ2 2026: 29 institutions
Value heldQ1 2024: $54.4M
Q1 2021: $786.5MQ2 2021: $558.8MQ3 2021: $419.1MQ4 2021: $277.7MQ1 2022: $133.2MQ2 2022: $99.6MQ3 2022: $49.3MQ4 2022: $51.6MQ1 2023: $34.0MQ2 2023: $31.4MQ3 2023: $21.3MQ4 2023: $33.1MQ1 2024: $54.4MQ2 2024: $32.0MQ3 2024: $27.1MQ4 2024: $21.6MQ1 2025: $12.8MQ2 2025: $13.0MQ3 2025: $13.2MQ4 2025: $18.6MQ1 2026: $13.8MQ2 2026: $6.82M
Institutions holding PASG and their total value by quarter
QuarterHoldersValue
Q2 202629$6.82M
Q1 202635$13.8M
Q4 202530$18.6M
Q3 202532$13.2M
Q2 202541$13.0M
Q1 202542$12.8M
Q4 202446$21.6M
Q3 202445$27.1M
Q2 202445$32.0M
Q1 202451$54.4M
Q4 202352$33.1M
Q3 202351$21.3M
Q2 202356$31.4M
Q1 202359$34.0M
Q4 202268$51.6M
Q3 202276$49.3M
Q2 202287$99.6M
Q1 2022110$133.2M
Q4 2021102$277.7M
Q3 2021103$419.1M
Q2 2021102$558.8M
Q1 202190$786.5M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q4 2023.

Institutions holding PASG in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
CWM, LLC5$00.00%00.0%Unchanged
TSFG, LLC100$00.00%00.0%Unchanged
Bank of America Corp1$10.00%−31−96.9%Reduced
Qube Research & Technologies Ltd4$50.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec10$140.00%−5,000−99.8%Reduced
Tower Research Capital LLC (TRC)34$460.00%+34New
Group One Trading, L.P.47$630.00%00.0%Unchanged
Advisor Group Holdings, Inc.217$2930.00%00.0%Unchanged
LRI Investments, LLC225$3040.00%+225New
JPMorgan Chase & Co273$3690.00%−1,104−80.2%Reduced
Wells Fargo & Company309$4170.00%+5+1.6%Added
Royal Bank of Canada500$1.00K0.00%+121+31.9%Added
Rhumbline Advisers783$1.06K0.00%00.0%Unchanged
Federated Hermes, Inc.783$1.06K0.00%+783New
Citigroup Inc3,969$5.36K0.00%−829−17.3%Reduced
Cubist Systematic Strategies, LLC11,290$15.2K0.00%+11,290New
Barclays PLC13,153$17.8K0.00%00.0%Unchanged
Morgan Stanley13,837$18.7K0.00%00.0%Unchanged
FMR LLC21,070$28.4K0.00%−40,951−66.0%Reduced
HighTower Advisors, LLC21,763$29.0K0.00%−501−2.3%Reduced
Marshall Wace, LLP21,990$29.7K0.00%+21,990New
Cresset Asset Management, LLC23,725$32.0K0.00%00.0%Unchanged
Virtu Financial LLC25,425$34.0K0.00%−42,279−62.4%Reduced
Goldman Sachs Group Inc26,954$36.4K0.00%+58+0.2%Added
XTX Topco Ltd42,963$58.0K0.01%+14,534+51.1%Added
DLK Investment Management, LLC64,000$86.4K0.04%00.0%Unchanged
Northern Trust Corp84,267$113.8K0.00%+7,382+9.6%Added
Marquette Asset Management, LLC85,500$115.4K0.02%00.0%Unchanged
State Street Corp123,873$167.2K0.00%00.0%Unchanged
Pale Fire Capital SE141,435$190.9K0.03%−439,822−75.7%Reduced
RBF Capital, LLC142,807$192.8K0.01%00.0%Unchanged
Two Sigma Investments, LP201,153$271.6K0.00%00.0%Unchanged
Two Sigma Advisers, LP209,600$283.0K0.00%−900−0.4%Reduced
Fiduciary Trust Co215,000$290.3K0.00%+100,000+87.0%Added
Citadel Advisors LLC221,552$299.1K0.00%−90,161−28.9%Reduced
Affinity Asset Advisors, LLC264,266$356.8K0.06%+264,266New
Geode Capital Management, LLC384,278$518.9K0.00%+52,075+15.7%Added
Acuitas Investments, LLC469,306$633.6K0.32%+51,572+12.3%Added
Bridgeway Capital Management, LLC556,142$750.8K0.02%+49,542+9.8%Added
Millennium Management LLC865,739$1.17M0.00%+77,564+9.8%Added
BlackRock Inc.922,547$1.25M0.00%−100,016−9.8%Reduced
Acadian Asset Management LLC961,271$1.30M0.00%+356,593+59.0%Added
Renaissance Technologies LLC1,205,524$1.63M0.00%−17,827−1.5%Reduced
Tang Capital Management LLC1,500,000$2.02M0.21%−900,000−37.5%Reduced
Vanguard Group Inc2,071,538$2.80M0.00%+52,656+2.6%Added
Erste Asset Management GmbH2,455,800$3.31M0.05%−505,000−17.1%Reduced
New Leaf Venture Partners, L.L.C.2,497,922$3.37M2.95%00.0%Unchanged
Vestal Point Capital, LP4,500,000$6.08M0.50%+4,500,000New
Lynx1 Capital Management LP4,845,871$6.54M1.68%+4,466,712+1,178.1%Added
Versant Venture Management, LLC4,959,769$6.70M6.49%00.0%Unchanged
OrbiMed Advisors LLC10,124,576$13.7M0.27%00.0%Unchanged
Weiss Multi-Strategy Advisers LLC0$00.00%−242,900−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−40,327−100.0%Sold out
Scientech Research LLC0$00.00%−18,853−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−18,533−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−13,647−100.0%Sold out
Simplex Trading, LLC0$00.00%−2,089−100.0%Sold out
UBS Group AG0$00.00%−1,059−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−1,010−100.0%Sold out